Alejandra Ortiz-Ruiz (Alejandra Leivas)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Kidney Transplantation

Endoplasmic Reticulum Stress

Tyrosine Kinase

Natural Killer Cells

Top Venues

Scientific reports

Blood cancer journal

Universidad Complutense de madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universidad Complutense de madrid Mar 01 2012 - May 30 2017

Spain

PHD

Universidad Autonoma de Madrid Facultad de Medicina Oct 04 2010 - Oct 11 2011

Spain

MSC :: Pharmacology and Therapeutics

Universidad Complutense de Madrid Facultad de Biología - Jun 30 2010

Spain

BSC

Publications

Estéfani García-Ríos, Alejandra Ortiz-Ruiz, Francisco J Mancebo, Laura Sánchez-Vega, Diego Lanzarot, Jose María Aguado, Joaquin Martinez Lopez, María-Liz Paciello-Coronel, Pilar Pérez-Romero
Isolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19. Biomedicines 10 (3) (2022)
Alejandra Ortiz-Ruiz, Antonio Valeri, Laura Córdoba, Almudena García-Ortiz, Alejandra Ortiz-Ruiz, Laura Sánchez-Vega, Osvaldo Graña-Castro, Lucía Fernández, Gonzalo Carreño-Tarragona, Manuel Pérez, Diego Megías, María Liz Paciello, José María Sánchez-Pina, Antonio Pérez-Martínez, Dean A Lee, Daniel J Powell, Paula Río, Joaquin Martinez Lopez
NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma. Blood cancer journal 11 (8) (2021)
Maria Luz Morales, Alicia Arenas, Alejandra Ortiz-Ruiz, Alejandra Leivas, Inmaculada Rapado, Alba Rodríguez-García, Nerea Castro, Ivana Zagorac, Miguel Quintela-Fandino, Gonzalo Gómez-López, Miguel Gallardo, Rosa Ayala, María Linares, Joaquín Martínez-López
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia. Scientific reports 9 (1) (2019)